Pediatric Antimicrobial Usage in a Secondary Care Hospital in Ras Al Khaimah, United Arab Emirates

ABSTRACT

Objectives: To assess the pattern of antimicrobial use among pediatric inpatients in a secondary care hospital in the United Arab Emirates. Materials and Methods: The prospective study was conducted based on the electronic records of 600 patients, collected over a period of 11 months, from September 2020 to July 2021. The primary patient population was the pediatric patients receiving antimicrobials admitted to Saqr Hospital, Ras Al Khaimah (RAK), United Arab Emirates (UAE). The data gathered includes general patient information, lab investigations, diagnoses, chronic medical conditions, and antimicrobials used. The number of defined daily doses (DDDs) administered per patient was calculated for each antimicrobial prescribed as per the WHO anatomical therapeutic chemical classification. Results: Out of 1400 patients admitted to the pediatric unit during the 11-month study period, 600 (42.8%) received antimicrobials. The mean duration of hospital stay was 3.44 days, and each patient received a mean of 1.41 antimicrobials per prescription. The mean days of antimicrobial therapy were 6.9 days. The majority of the patients were aged 0–5 years (61.1%), and 58% of the total sample was male. Amongst a total of 41 different antimicrobials prescribed, the beta-lactam co-amoxiclav (J01CR02) was the most frequently (19.3%) used one, followed by cefuroxime (J01DC02) (16.3%), amoxicillin (J01CA04) (15.0%), and azithromycin (J01FA10) (5.99%). These were administered mainly via the parenteral route, and the most common indication was respiratory disease. Conclusion: Our study concludes that most of the prescribed antimicrobials for pediatric patients are within the WHO access and watch group. Co-amoxiclav, cefuroxime, and amoxicillin are the most frequently used antimicrobials. The main indication for use was respiratory illness.

KEYWORDS

• Pediatric antimicrobials
• antimicrobial usage
• antimicrobial resistance
• antibiotic prescription
• prescribing patterns
• Children inpatients
• United Arab Emirates

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/0976500X231203845Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 14, ISSUE 2Allelic Variants in the Warfarin-related Genes VKORC1 and CYP2C9 in a Western Saudi PopulationAmina M. Bagher, Wedyan S. Alharbi, Lamees S. Gadi, Lenah S. Binmahfouz, Rawan H Hareeri · pp. 125–132Research ArticleSame type: Article
• Article · VOLUME 14, ISSUE 2Quercetin Exerts a Protective Effect on Ischemic Stroke-induced Memory Deficits in MiceChrismawan Ardianto, Dewi Lestari, Luthfia Hany Primadani, Dwi Retno Puspitasari, I Nengah Budi Sumartha, Khoirotin Nisak, Aniek Setiya Budiatin, Dewi Wara Shinta, Mareta Rindang Andarsari, Farida Ifadotunnikmah, Amar Daud Iskandar Abdullah, Mahardian Rahmadi, Junaidi Khotib · pp. 133–141Research ArticleSame type: Article
• Article · VOLUME 14, ISSUE 2N-Acetyl-l-Cysteine Ameliorations Renal Function Early After Renal Ischemia and Reperfusion; it is not Protective over a Long Term under a High-Sodium Diet in RatsRafael Canavel Pereira, Carolina Martinez Romão, Beatriz Santos Geoffroy Corrêa, Wagner Vasques Dominguez, Luzia Naôko Shinohara Furukawa · pp. 142–152Research ArticleSame type: Article
• Article · VOLUME 14, ISSUE 2The Science of Antioxidants: Balancing the Pros and Cons for Our HealthMueen Ahmed K. K. · pp. 160–162Same type: Article